In 2011, the Chinese market for cardiac surgery devices was valued at $106 million, an increase of 10.3% from the previous year.
We provide a detailed analysis of the competative landscape including market shares and qualitative discussions of the leading and upcoming competitors in each market segment.
Identify Strategic Opportunities, Customer Feedback and Market Monitoring, Market Overview by Segment, Trend Analysis by Segment, Market Drivers & Limiters, Mergers & Acqusitions.Market Overview by Segment, Trend Analysis by Segment, Market Drivers & Limiters, Mergers & Acqusitions.
TOTAL CHINESE CARDIAC SURGERY, TISSUE HEART VALVE, MECHANICAL HEART VALVE, ANNULOPLASTY REPAIR DEVICE, ON & OFF-PUMP CORONARY ARTERY BYPASS GRAFT DEVICE, ENDOSCOPIC VESSEL HARVESTING DEVICE, ANASTOMOSIS ASSIST DEVICE, CARDIAC ABLATION DEVICE, VENTRICULAR ASSIST DEVICE , INTRA-AORTIC BALLOON PUMP DEVICE, PFO AND ATRIAL AND SEPTAL DEFECT REPAIR DEVICE. In Depth: HEART VALVE PROCEDURES.